Florian joined Speransa Therapeutics in 2021 as Chief Operating Officer.
He has been working in the pharmaceutical industry for close to ten years. During that time, he has held positions in corporate finance, mergers & acquisitions and global controlling. Prior to joining Speransa Therapeutics, Florian was leading the global financial reporting and planning of Boehringer Ingelheim’s Innovation Unit. Before that, Florian was responsible for leading numerous M&A, carve-out and integration projects both in a corporate setting as well as an advisor in Frankfurt and London.
Florian holds a diploma in Business Administration from European Business School, Oestrich-Winkel with a focus on Finance and Information Systems.